HPLC–MS–MS Analysis of Zebrafish Embryos
Scientists from the Helmholtz Centre for Environmental Research in Germany, have developed a high performance liquid chromatography tandem mass spectrometry (HPLC–MS–MS) method to determine the internal concentrations of 34 test compounds in zebrafish (Danio rerio) embryos.
Scientists from the Helmholtz Centre for Environmental Research in Germany, have developed a high performance liquid chromatography tandem mass spectrometry (HPLC–MS–MS) method to determine the internal concentrations of 34 test compounds in zebrafish (Danio rerio) embryos.1
Zebrafish embryos (ZFE) can be used in toxicity tests instead of adult fish to determine the safety level of compounds. It is important to quantify internal concentrations of a compound in ZFE to understand why it exerts an effect or not. Stephan Brox told The Column: “Since the zebrafish embryo has become a well-established model organism in the field of (eco)toxicology, it is important to gain more data on uptake processes and internal concentrations. So far, observed effects on test organisms are often correlated to an external concentration in the exposure medium. However, for a better understanding why a specific compound may or may not exhibit toxic effects, internal concentrations have to be considered too.”
Fertilized eggs were exposed to polar chemicals, such as clofibric acid or metribuzin, and were subsequently extracted using methanol. Extracts were analyzed using HPLC–MS–MS and different internal concentration-time profiles were observed, according to Brox. When asked to comment on the challenges of developing the method, Brox told The Column that the small size of the ZFE and their fast development were challenging because the internal concentrations could be very low. He added: “Furthermore the developing organism may also lead to changing matrix effects during the electrospray ionization process at different life‑stages of the organism. During the method development we considered all these challenges and the presented method is suitable for the determination of internal concentrations at early life-stages of the organism.”
Reference
1. S. Brox et al., Anal. Bioanal. Chem. 406, 4831–4840 (2014).
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
